Publications

Publications from OUS - Section for sarcoma and melanoma

357 publications found

Publications 2025

1. Berner K, Hernes E, Kvassheim M, Revheim ME, Bastiansen J, Selboe S, Bakken CL, Grønningsæter SR, Bruland ØS, Larsen RH, Bouzelmat L, Jardine VL, Stokke C (2025)
   First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted ²¹²Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer
   J Nucl Med, 66 (5), 732-738
   DOI 10.2967/jnumed.124.269299, PubMed 40081958
2. Connolly EA, Boye K, Bonvalot S, Kratz CP, Leithner A, Malkin D, Messiou C, Miah AB, Pantziarka P, Timmermann B, van der Graaf WTA, Thomas DM, Stacchiotti S (2025)
   Genetic predisposition in sarcomas: clinical implications and management
   EClinicalMedicine, 83, 103203
   DOI 10.1016/j.eclinm.2025.103203, PubMed 40291347
3. Dávila Fajardo R, Magelssen H, Cameron AL, Boterberg T, Mandeville HC (2025)
   Current and Future Developments in Radiation Oncology Approach for Rhabdomyosarcoma
   Cancers (Basel), 17 (10)
   DOI 10.3390/cancers17101618, PubMed 40427117
4. Heinrich MC, Blay JY, Gelderblom H, George S, Schöffski P, von Mehren M, Zalcberg JR, Jones RL, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Boye K, Goldstein D, Sánchez C, Siontis BL, Cox P, Davis E, Sherman ML, Ruiz-Soto R, Bauer S (2025)
   Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE
   J Clin Oncol, 43 (20), 2239-2244
   DOI 10.1200/JCO-24-02818, PubMed 40408605
5. Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A (2025)
   Therapeutic evaluation of [²¹²Pb]Pb-AB001 and [¹⁷⁷Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer
   Eur J Nucl Med Mol Imaging (in press)
   DOI 10.1007/s00259-025-07330-y, PubMed 40397137
6. Koffi E, Padilla CS, Drabbe C, Schreuder WH, Zemouri C, den Hollander D, Grünhagen DJ, Sodergren S, Singer S, Jones RL, Desar IME, Fauske L, Pinto M, Nixon I, Salah S, Bruland ØS, Soomers VLMN, van de Sande MAJ, de Haan JJ, Verhoef C, Steggink LC, van Houdt WJ, Bootsma TI, Tesselaar MT, van der Graaf WTA et al. (2025)
   Health-Related Quality of Life in Patients With a Head and Neck Sarcoma: A Mixed-Methods Study
   Head Neck (in press)
   DOI 10.1002/hed.28226, PubMed 40583369
7. Kokkali S, Dolcan A, Boye K, Kyriazoglou A, Boukovinas I, Kalofonou F, Koumarianou A, Asimakopoulou N, Vorrias E, Tsapakidis K, Georgaki E, Boulouta A, Mavroeidis L, Harneshaug M, Theocharis S, Jones RL, Digklia A (2025)
   Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutions
   Acta Oncol, 64, 761-768
   DOI 10.2340/1651-226X.2025.43135, PubMed 40495323
8. Singh HV, Nakken E, Fauske L (2025)
   Bridging cultural and linguistic barriers: South Asian minority women's experiences of radiotherapy for cervical cancer in Norway
   Tech Innov Patient Support Radiat Oncol, 34, 100315
   DOI 10.1016/j.tipsro.2025.100315, PubMed 40496552
9. Ullmann Miller J, Fauske L, Sigurdardottir S, Arfa S, von der Lippe C (2025)
   'In the dark': parents' lifelong commitment to supporting children with Bardet-Biedl syndrome
   Health Psychol Behav Med, 13 (1), 2467432
   DOI 10.1080/21642850.2025.2467432, PubMed 39968158
10. Wens FSPL, Zonca F, van Tinteren H, Timmermann B, Laprie A, Boterberg T, Gaze M, Lim P, Jazmati D, Dieckmann K, Vennarini S, Melchior P, Weber B, Albiac MR, Szulc A, Grigorenko V, Magelssen H, van Beek K, Graf N, Papadakis V, Neggers SJCMM, van den Heuvel-Eibrink MM, Janssens GO, Polak R (2025)
    Late toxicity after upper abdominal radiotherapy in pediatric Wilms tumor and neuroblastoma survivors. A systematic review on behalf of SIOPEN and SIOP-RTSG
    Radiother Oncol, 209, 110961
    DOI 10.1016/j.radonc.2025.110961, PubMed 40441488
11. Yip D, Zalcberg J, Blay JY, Eriksson M, Espinoza D, Price T, Marreaud S, Italiano A, Steeghs N, Boye K, Underhill C, Gebski V, Simes J, Gelderblom H, Joensuu H (2025)
    Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial
    Br J Cancer, 132 (10), 897-904
    DOI 10.1038/s41416-025-02983-w, PubMed 40133509

Publications 2024

1. Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P (2024)
   The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
   J Neurooncol, 169 (1), 137-145
   DOI 10.1007/s11060-024-04709-z, PubMed 38762830
2. Cameron AL, Mandeville H, Coppadoro B, Periasamy M, Davila Fajardo R, Ferrari A, Gaze MN, Helfre S, Magelssen H, Minard-Colin V, Ramos M, Schoot R, Zanetti I, Bisogno G, Chisholm JC, Merks JHM (2024)
   The Impact of Radiation Therapy on Metastatic Rhabdomyosarcoma: Results From the EpSSG MTS 2008 Study
   Int J Radiat Oncol Biol Phys, 121 (2), 388-402
   DOI 10.1016/j.ijrobp.2024.08.039, PubMed 39222824
3. Dávila Fajardo R, Scarzello G, Gaze MN, Boterberg T, Cameron A, Fuchs J, Guérin F, Hoskin P, Krasin MJ, Kroon P, Magelssen H, Mercke C, Merks JHM, Paulsen F, Pommier P, Ramos M, Rees H, Rogers T, Schmid M, Seitz G, Slater O, Smeulders N, Stenman J, Terwisscha S, Chargari C et al. (2024)
   Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines
   Radiother Oncol, 195, 110273
   DOI 10.1016/j.radonc.2024.110273, PubMed 38588921
4. Gelderblom H, Bhadri V, Stacchiotti S, Bauer S, Wagner AJ, van de Sande M, Bernthal NM, López Pousa A, Razak AA, Italiano A, Ahmed M, Le Cesne A, Tinoco G, Boye K, Martín-Broto J, Palmerini E, Tafuto S, Pratap S, Powers BC, Reichardt P, Casado Herráez A, Rutkowski P, Tait C, Zarins F, Harrow B et al. (2024)
   Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
   Lancet, 403 (10445), 2709-2719
   DOI 10.1016/S0140-6736(24)00885-7, PubMed 38843860
5. Green D, van Ewijk R, Tirtei E, Andreou D, Baecklund F, Baumhoer D, Bielack SS, Botchu R, Boye K, Brennan B, Capra M, Cottone L, Dirksen U, Fagioli F, Fernandez N, Flanagan AM, Gambarotti M, Gaspar N, Gelderblom H, Gerrand C, Gomez-Mascard A, Hardes J, Hecker-Nolting S, Kabickova E, Kager L et al. (2024)
   Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement
   Clin Cancer Res, 30 (16), 3395-3406
   DOI 10.1158/1078-0432.CCR-24-0101, PubMed 38869831
6. Heramb-Aamot J, Mala T, Fauske L (2024)
   Everyday Life Six to Eight Months After Esophagectomy for Cancer: A Qualitative Study
   Anticancer Res, 44 (2), 743-750
   DOI 10.21873/anticanres.16865, PubMed 38307550
7. Hompland I, Boye K, Wiedswang AM, Papakonstantinou A, Røsok B, Joensuu H, Bruland Ø (2024)
   Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study
   Acta Oncol, 63, 288-293
   DOI 10.2340/1651-226X.2024.39851, PubMed 38712513
8. Joensuu H, Reichardt A, Eriksson M, Hohenberger P, Boye K, Cameron S, Lindner LH, Jost PJ, Bauer S, Schütte J, Lindskog S, Kallio R, Jaakkola PM, Goplen D, Wardelmann E, Reichardt P (2024)
   Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial
   Br J Cancer, 131 (2), 299-304
   DOI 10.1038/s41416-024-02738-z, PubMed 38862742
9. Larsen SG, Graf W, Larsen RH, Revheim ME, Mariathasan AM, Sørensen O, Spasojevic M, Rashid G, Lundstrøm N, Gjertsen TJ, Aksnes AK, Bruland ØS (2024)
   Eighteen-Months Safety and Efficacy Following Intraperitoneal Treatment With ²²⁴Radium-Labeled Microparticles After CRS-HIPEC in Patients With Peritoneal Metastasis From Colorectal Cancer
   J Surg Oncol, 130 (6), 1395-1402
   DOI 10.1002/jso.27897, PubMed 39428687
10. Machak GN, Bruland ØS, Romanova TN, Kovalev AV (2024)
    Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal
    J Bone Oncol, 45, 100596
    DOI 10.1016/j.jbo.2024.100596, PubMed 38545297
11. Mediå LM, Fauske L, Sigurdardottir S, Billaud Feragen KJ, Waehre A (2024)
    Differences of sex development and surgical decisions: focus group interviews with health care professionals in Norway
    Health Psychol Behav Med, 12 (1), 2371134
    DOI 10.1080/21642850.2024.2371134, PubMed 38979393
12. Os SS, Skipar K, Skovlund E, Hompland I, Hellebust TP, Guren MG, Lindemann K, Nakken ES (2024)
    Survival prediction in patients with gynecological cancer irradiated for brain metastases
    Acta Oncol, 63, 206-212
    DOI 10.2340/1651-226X.2023.34899, PubMed 38647023
13. Riba M, Sala C, Culhane AC, Flobak Å, Patocs A, Boye K, Plevova K, Pospíšilová Š, Gandolfi G, Morelli MJ, Bucci G, Edsjö A, Lassen U, Al-Shahrour F, Lopez-Bigas N, Hovland R, Cuppen E, Valencia A, Poirel HA, Rosenquist R, Scollen S, Arenas Marquez J, Belien J, De Nicolo A, De Maria R et al. (2024)
    The 1+Million Genomes Minimal Dataset for Cancer
    Nat Genet, 56 (5), 733-736
    DOI 10.1038/s41588-024-01721-x, PubMed 38702538
14. Zhou Y, Ray PS, Zhu J, Stein F, Rettel M, Sekaran T, Sahadevan S, Perez-Perri JI, Roth EK, Myklebost O, Meza-Zepeda LA, von Deimling A, Fu C, Brosig AN, Boye K, Nathrath M, Blattmann C, Lehner B, Hentze MW, Kulozik AE (2024)
    Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
    Nat Commun, 15 (1), 2810
    DOI 10.1038/s41467-024-47031-y, PubMed 38561347
15. Østergaard DE, Embring A, Sehested A, Magelssen H, Vogelius IR, Kjærsgaard M, Nysom K, Mathiasen R, Lukacova S, Maraldo MV (2024)
    REMIT: Reirradiation of Diffuse Midline Glioma Patients -A Nordic Society of Paediatric Haematology and Oncology Feasibility Study
    Clin Oncol (R Coll Radiol), 37, 103682
    DOI 10.1016/j.clon.2024.103682, PubMed 39626445

Publications 2023

1. Berndsen M, Renberg S, Hølmebakk T, Hancke E, Puls F, Karlsson F, Stoldt S, Bjerkehagen B, Haglund de Flon F, Muth A, Papakonstantinou A, Boye K, Lindskog S (2023)
   Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy
   Br J Surg, 110 (12), 1857-1862
   DOI 10.1093/bjs/znad309, PubMed 37758514
2. Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P (2023)
   Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
   Neurooncol Pract, 11 (1), 36-45
   DOI 10.1093/nop/npad063, PubMed 38222046
3. Boye K, Gorunova L, Gunawan B, Hompland I, Sander B, Panagopoulos I, Langer C, Golas M, Heim S, Füzesi L, Hølmebakk T, Micci F (2023)
   Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor
   JCO Precis Oncol, 7, e2200351
   DOI 10.1200/PO.22.00351, PubMed 36724411
4. Bruland ØS, Larsen RH, Baum RP, Juzeniene A (2023)
   Editorial: Targeted alpha particle therapy in oncology
   Front Med (Lausanne), 10, 1165747
   DOI 10.3389/fmed.2023.1165747, PubMed 36960341
5. Fauske L, Jebsen NL, Bondevik H, Bruland ØS (2023)
   Exploring the Patient Perspective of Bone Sarcoma Survivors Who Have Undergone Particle Radiotherapy Abroad
   Anticancer Res, 43 (5), 2031-2039
   DOI 10.21873/anticanres.16364, PubMed 37097689
6. Gelderblom H, Jones RL, Blay JY, George S, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Siontis BL, Goldstein D, Boye K, Sanchez C, Steeghs N, Rutkowski P, Druta M, Serrano C, Somaiah N, Chi P, Harrow B, Becker C, Reichmann W, Sherman ML et al. (2023)
   Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
   Eur J Cancer, 192, 113245
   DOI 10.1016/j.ejca.2023.113245, PubMed 37598656
7. Grønningsæter SR, Blakkisrud J, Selboe S, Revheim ME, Bruland ØS, Bønsdorff TB, Larsen SG, Stokke C (2023)
   Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis
   Front Med (Lausanne), 10, 1058914
   DOI 10.3389/fmed.2023.1058914, PubMed 36844217
8. Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P et al. (2023)
   Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
   BMJ Open, 13 (3), e070071
   DOI 10.1136/bmjopen-2022-070071, PubMed 36940951
9. Høland M, Berg KCG, Eilertsen IA, Bjerkehagen B, Kolberg M, Boye K, Lingjærde OC, Guren TK, Mandahl N, van den Berg E, Palmerini E, Smeland S, Picci P, Mertens F, Sveen A, Lothe RA (2023)
   Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets
   EBioMedicine, 97, 104829
   DOI 10.1016/j.ebiom.2023.104829, PubMed 37837931
10. Janik AM, Terlecka A, Spałek MJ, Boye K, Szostakowski B, Chmiel P, Szumera-Ciećkiewicz A, Bobak K, Świtaj T, Rutkowski P, Czarnecka AM (2023)
    Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors
    Cancers (Basel), 15 (24)
    DOI 10.3390/cancers15245854, PubMed 38136399
11. Jesse S, Kuhlmann L, Hildebrand LS, Magelssen H, Schmaus M, Timmermann B, Andres S, Fietkau R, Distel LV (2023)
    Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome
    Cells, 12 (5)
    DOI 10.3390/cells12050820, PubMed 36899955
12. Joensuu H, Wardelmann E, Eriksson M, Reichardt A, Hall KS, Schütte J, Cameron S, Hohenberger P, Sihto H, Jost PJ, Lindner LH, Bauer S, Nilsson B, Kallio R, Pesonen T, Reichardt P (2023)
    KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
    Clin Cancer Res, 29 (17), 3313-3319
    DOI 10.1158/1078-0432.CCR-22-3980, PubMed 37014660
13. Juzeniene A, Stenberg VY, Bruland ØS, Revheim ME, Larsen RH (2023)
    Dual targeting with ²²⁴Ra/²¹²Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
    Front Med (Lausanne), 9, 1051825
    DOI 10.3389/fmed.2022.1051825, PubMed 36733936
14. Larsen SG, Graf W, Mariathasan AB, Sørensen O, Spasojevic M, Goscinski MA, Selboe S, Lundstrøm N, Holtermann A, Revheim ME, Bruland ØS (2023)
    First experience with ²²⁴Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)
    Front Med (Lausanne), 10, 1070362
    DOI 10.3389/fmed.2023.1070362, PubMed 36936230
15. Leske H, Blakstad H, Lund-Iversen M, Skovholt EK, Niehusmann P, Ramm-Pettersen JT, Skogen K, Kongelf G, Sprauten M, Magelssen H, Brandal P (2023)
    Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A
    Neuropathology, 43 (5), 385-390
    DOI 10.1111/neup.12895, PubMed 36754566
16. Lloret I, Hompland I, Lobmaier IV, Sundseth J, Server A (2023)
    Ewing sarcoma of the temporal bone with aneurysmal bone cyst-like changes: A rare case report with an unusual radiological presentation
    Neuroradiol J, 37 (5), 640-644
    DOI 10.1177/19714009231212358, PubMed 37923348
17. Mediå LM, Sigurdardottir S, Fauske L, Waehre A (2023)
    Understanding sexual health concerns among adolescents and young adults with differences of sex development: a qualitative study
    Int J Qual Stud Health Well-being, 18 (1), 2204635
    DOI 10.1080/17482631.2023.2204635, PubMed 37092307
18. Mensali N, Köksal H, Joaquina S, Wernhoff P, Casey NP, Romecin P, Panisello C, Rodriguez R, Vimeux L, Juzeniene A, Myhre MR, Fåne A, Ramírez CC, Maggadottir SM, Duru AD, Georgoudaki AM, Grad I, Maturana AD, Gaudernack G, Kvalheim G, Carcaboso AM, de Alava E, Donnadieu E, Bruland ØS, Menendez P et al. (2023)
    ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
    Nat Commun, 14 (1), 3375
    DOI 10.1038/s41467-023-39097-x, PubMed 37291203
19. Namløs HM, Khelik K, Nakken S, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2023)
    Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential
    Mol Oncol, 17 (11), 2432-2450
    DOI 10.1002/1878-0261.13514, PubMed 37622176
20. Palmerini E, Reichardt P, Hall KS, Bertulli R, Bielack SS, Comandone A, Egerer G, Hansmeier A, Kevric M, Carretta E, Hansson L, Jebsen N, Eriksson M, Bruland ØS, Donati DM, Ibrahim T, Smeland S, Ferrari S (2023)
    Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.)
    Cancer, 129 (22), 3564-3573
    DOI 10.1002/cncr.34964, PubMed 37530385
21. Solbakken AM, Sellevold S, Spasojevic M, Julsrud L, Emblemsvåg HL, Reims HM, Sørensen O, Thorgersen EB, Fauske L, Ågren JSM, Brennhovd B, Ryder T, Larsen SG, Flatmark K (2023)
    Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
    Ann Surg Oncol, 30 (12), 7602-7611
    DOI 10.1245/s10434-023-13964-9, PubMed 37481493
22. Thorgersen EB, Asvall J, Schjalm C, McAdam KE, Bruland ØS, Larsen SG, Mollnes TE (2023)
    Effect of Intraperitoneal ²²⁴Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy
    Technol Cancer Res Treat, 22, 15330338231192902
    DOI 10.1177/15330338231192902, PubMed 37574949
23. Turcas A, Kelly SM, Bernier-Chastagner V, Bolle S, Cameron A, Corning C, Clementel E, Dieckmann K, Davila Fajardo R, Gaze MN, Laprie A, Magelssen H, Meroni S, Pignoli E, Safwat A, Scarzello G, Talbot J, Timmermann B, Boterberg T, Mandeville HC (2023)
    Management of the vertebrae as an organ at risk in paediatric radiotherapy clinical trials: Initial QUARTET experience
    Radiother Oncol, 187, 109810
    DOI 10.1016/j.radonc.2023.109810, PubMed 37468069
24. van de Wal D, Fauske L, Bruland ØS, Jones RL, Kasper B, Wilson R, van der Graaf WTA, Husson O (2023)
    Psychological and social challenges of patients with locally advanced and metastatic gastrointestinal stromal tumours (GIST) on long-term treatment with tyrosine kinase inhibitors: a qualitative study with patients and medical oncologists
    Support Care Cancer, 31 (6), 352
    DOI 10.1007/s00520-023-07810-7, PubMed 37233829
25. van Ewijk R, Cleirec M, Herold N, le Deley MC, van Eijkelenburg N, Boudou-Rouquette P, Risbourg S, Strauss SJ, Palmerini E, Boye K, Kager L, Hecker-Nolting S, Marchais A, Gaspar N, FOSTER Consortium (Fight OsteoSarcoma Through European Research), work package 3 on recurrent/refractory osteosarcoma trials (2023)
    A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
    Cancer Treat Rev, 120, 102625
    DOI 10.1016/j.ctrv.2023.102625, PubMed 37738712
26. Wallander K, Öfverholm I, Boye K, Tsagkozis P, Papakonstantinou A, Lin Y, Haglund de Flon F (2023)
    Sarcoma care in the era of precision medicine
    J Intern Med, 294 (6), 690-707
    DOI 10.1111/joim.13717, PubMed 37643281
27. Werlenius K, Kinhult S, Solheim TS, Magelssen H, Löfgren D, Mudaisi M, Hylin S, Bartek J, Strandéus M, Lindskog M, Rashid HB, Carstam L, Gulati S, Solheim O, Bartek J, Salvesen Ø, Jakola AS (2023)
    Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial
    JAMA Netw Open, 6 (3), e234149
    DOI 10.1001/jamanetworkopen.2023.4149, PubMed 37000452

Publications 2022

1. Barnes DJ, Dutton P, Bruland Ø, Gelderblom H, Faleti A, Bühnemann C, van Maldegem A, Johnson H, Poulton L, Love S, Tiemeier G, van Beelen E, Herbschleb K, Haddon C, Billingham L, Bradley K, Ferrari S, Palmerini E, Picci P, Dirksen U, Strauss SJ, Hogendoorn PCW, Buddingh E, Blay JY, Cleton-Jansen AM et al. (2022)
   Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
   BMC Cancer, 22 (1), 629
   DOI 10.1186/s12885-022-09697-9, PubMed 35672690
2. Boye K, Lobmaier I, Kobbeltvedt MR, Thorkildsen J, Taksdal I, Bjerkehagen B, Bruland ØS, Zaikova O, Sundby Hall K, Hompland I (2022)
   Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study
   Acta Oncol, 61 (7), 793-800
   DOI 10.1080/0284186X.2022.2082259, PubMed 35698755
3. Fauske L, Wærstad PH, Hompland I, Bruland ØS (2022)
   Hope as a Lifeline: Imatinib Discontinuation in Patients With Oligometastatic Gastrointestinal Stromal Tumours
   Anticancer Res, 42 (2), 955-963
   DOI 10.21873/anticanres.15555, PubMed 35093895
4. Georgiesh T, Aggerholm-Pedersen N, Schöffski P, Zhang Y, Napolitano A, Bovée JVMG, Hjelle Å, Tang G, Spalek M, Nannini M, Swanson D, Baad-Hansen T, Sciot R, Hesla AC, Huang P, Dorleijn D, Haugland HK, Lacambra M, Skoczylas J, Pantaleo MA, Haas RL, Meza-Zepeda LA, Haller F, Czarnecka AM, Loong H et al. (2022)
   Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour
   Br J Cancer, 127 (10), 1793-1798
   DOI 10.1038/s41416-022-01959-4, PubMed 36030294
5. Gorunova L, Boye K, Panagopoulos I, Berner JM, Bjerkehagen B, Hompland I, Lobmaier I, Hølmebakk T, Hveem TS, Heim S, Micci F (2022)
   Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
   Oncotarget, 13, 508-517
   DOI 10.18632/oncotarget.28209, PubMed 35284037
6. Mediå LM, Fauske L, Sigurdardottir S, Feragen KJB, Heggeli C, Wæhre A (2022)
   'It was Supposed to be a Secret': a study of disclosure and stigma as experienced by adults with differences of sex development
   Health Psychol Behav Med, 10 (1), 579-595
   DOI 10.1080/21642850.2022.2102018, PubMed 35898596
7. Pulkka OP, Viisanen L, Tynninen O, Laaksonen M, Reichardt P, Reichardt A, Eriksson M, Hall KS, Wardelmann E, Nilsson B, Sihto H, Joensuu H (2022)
   Fibrinogen-like protein 2 in gastrointestinal stromal tumour
   J Cell Mol Med, 26 (4), 1083-1094
   DOI 10.1111/jcmm.17163, PubMed 35029030
8. Schmid MP, Harrabi S, Herfarth K, Bruland ØS, Welzel T, Haberer T, Ellerbrock M, Debus J, Uhl M, Seidensaal K (2022)
   Particle Therapy in Adult Patients with Pelvic Ewing Sarcoma-Tumor and Treatment Characteristics and Early Clinical Outcomes
   Cancers (Basel), 14 (24)
   DOI 10.3390/cancers14246045, PubMed 36551530
9. Seidensaal K, Dostal M, Liermann J, Adeberg S, Weykamp F, Schmid MP, Freudlsperger C, Hoffmann J, Hompland I, Herfarth K, Debus J, Harrabi SB (2022)
   Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapy
   Front Oncol, 12, 927399
   DOI 10.3389/fonc.2022.927399, PubMed 36212490
10. Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, Caraceni A, Bajpai J, Baldi GG, Bernthal N, Blay JY, Boye K, Broto JM, Chen WT, Dei Tos PA, Desai J, Emhofer S, Eriksson M, Gronchi A, Gelderblom H, Hardes J, Hartmann W, Healey J, Italiano A, Jones RL et al. (2022)
    Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts
    Cancer Treat Rev, 112, 102491
    DOI 10.1016/j.ctrv.2022.102491, PubMed 36502615
11. Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A (2022)
    Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand ²¹²Pb-NG001
    Cancers (Basel), 14 (11)
    DOI 10.3390/cancers14112784, PubMed 35681766
12. Tornes AJK, Stenberg VY, Larsen RH, Bruland ØS, Revheim ME, Juzeniene A (2022)
    Targeted alpha therapy with the ²²⁴Ra/²¹²Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
    Front Med (Lausanne), 9, 1058863
    DOI 10.3389/fmed.2022.1058863, PubMed 36507500

Publications 2021

1. Boye K, Longhi A, Guren T, Lorenz S, Næss S, Pierini M, Taksdal I, Lobmaier I, Cesari M, Paioli A, Løndalen AM, Setola E, Hompland I, Meza-Zepeda LA, Sundby Hall K, Palmerini E (2021)
   Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
   Cancer Immunol Immunother, 70 (9), 2617-2624
   DOI 10.1007/s00262-021-02876-w, PubMed 33580363
2. Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dufresne A, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F et al. (2021)
   Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
   Ann Oncol, 33 (1), 20-33
   DOI 10.1016/j.annonc.2021.09.005, PubMed 34560242
3. Fauske L, Bruland ØS, Dahl AA, Myklebostad A, Reme SE (2021)
   Does the Lightning Process Training Programme Reduce Chronic Fatigue in Adolescent and Young Adult Cancer Survivors? A Mixed-Methods Pilot Study
   Cancers (Basel), 13 (16)
   DOI 10.3390/cancers13164076, PubMed 34439229
4. Georgiesh T, Namløs HM, Sharma N, Lorenz S, Myklebost O, Bjerkehagen B, Meza-Zepeda LA, Boye K (2021)
   Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour
   Pathology, 53 (6), 713-719
   DOI 10.1016/j.pathol.2020.11.010, PubMed 33745702
5. Hompland I, Ferrari S, Bielack S, Palmerini E, Hall KS, Picci P, Hecker-Nolting S, Donati DM, Blattmann C, Bjerkehagen B, Staals E, Kager L, Gambarotti M, Kühne T, Eriksson M, Ferraresi V, Kevric M, Biagini R, Baumhoer D, Brosjø O, Comandone A, Schwarz R, Bertulli R, Kessler T, Hansson L et al. (2021)
   Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
   Eur J Cancer, 151, 150-158
   DOI 10.1016/j.ejca.2021.04.017, PubMed 33990016
6. Hølmebakk T, Boye K (2021)
   ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
   Ann Surg Oncol, 28 (11), 6846-6847
   DOI 10.1245/s10434-021-09608-5, PubMed 33687615
7. Hølmebakk T, Boye K (2021)
   Correction to: ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
   Ann Surg Oncol, 28 (Suppl 3), 873
   DOI 10.1245/s10434-021-09939-3, PubMed 33829360
8. Hølmebakk T, Wiedswang AM, Meza-Zepeda LA, Hompland I, Lobmaier IVK, Berner JM, Stoldt S, Boye K (2021)
   Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
   Ann Surg Oncol, 28 (11), 6837-6845
   DOI 10.1245/s10434-021-09605-8, PubMed 33651216
9. Juzeniene A, Stenberg VY, Bruland ØS, Larsen RH (2021)
   Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
   Cancers (Basel), 13 (4)
   DOI 10.3390/cancers13040779, PubMed 33668474
10. Kerboeuf M, Koppang EO, Haaland AH, Lingaas F, Bruland ØS, Teige J, Moe L (2021)
    Early immunohistochemical detection of pulmonary micrometastases in dogs with osteosarcoma
    Acta Vet Scand, 63 (1), 41
    DOI 10.1186/s13028-021-00608-9, PubMed 34732227
11. Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL (2021)
    Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial
    JAMA Oncol, 7 (1), e205865
    DOI 10.1001/jamaoncol.2020.5865, PubMed 33180100
12. Mariathasan AB, Boye K, Dueland S, Flatmark K, Larsen SG (2021)
    Metastases in locally advanced rectal cancer undergoing curatively intended treatment
    Eur J Surg Oncol, 47 (9), 2377-2383
    DOI 10.1016/j.ejso.2021.04.023, PubMed 34049768
13. Mul J, Melchior P, Seravalli E, Saunders D, Bolle S, Cameron AL, Gurtner K, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Mandeville H, Boterberg T, Kroon PS, Kotte ANTJ, Hoeben BAW, van Rossum PSN, van Grotel M, Graf N, van den Heuvel-Eibrink MM, Rübe C, Janssens GO (2021)
    Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise
    Clin Transl Radiat Oncol, 28, 39-47
    DOI 10.1016/j.ctro.2021.03.001, PubMed 33796796
14. Napoli E, Bønsdorff TB, Jorstad IS, Bruland ØS, Larsen RH, Westrøm S (2021)
    Radon-220 diffusion from 224Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use
    PLoS One, 16 (3), e0248133
    DOI 10.1371/journal.pone.0248133, PubMed 33662039
15. Peneder P, Stütz AM, Surdez D, Krumbholz M, Semper S, Chicard M, Sheffield NC, Pierron G, Lapouble E, Tötzl M, Ergüner B, Barreca D, Rendeiro AF, Agaimy A, Boztug H, Engstler G, Dworzak M, Bernkopf M, Taschner-Mandl S, Ambros IM, Myklebost O, Marec-Bérard P, Burchill SA, Brennan B, Strauss SJ et al. (2021)
    Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
    Nat Commun, 12 (1), 3230
    DOI 10.1038/s41467-021-23445-w, PubMed 34050156
16. Revheim ME, Hole KH, Mo T, Bruland ØS, Reitan E, Julsrud L, Seierstad T (2021)
    Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors
    Acta Radiol, 63 (8), 995-1004
    DOI 10.1177/02841851211027389, PubMed 34171968
17. Spasojevic M, Mariathasan AB, Frich L, Bruland ØS, Larsen SG, Stoldt S (2021)
    [Cancer therapy with isolated limb perfusion]
    Tidsskr Nor Laegeforen, 141 (2021-12)
    DOI 10.4045/tidsskr.21.0194, PubMed 34505491
18. Stenberg VY, Larsen RH, Ma LW, Peng Q, Juzenas P, Bruland ØS, Juzeniene A (2021)
    Evaluation of the PSMA-Binding Ligand ²¹²Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
    Int J Mol Sci, 22 (9)
    DOI 10.3390/ijms22094815, PubMed 34062920
19. Switlyk MD, Niehusmann P, Sprauten M, Magelssen H, Aarhus M, Rasmussen FØ, Knutstad K, Brandal P (2021)
    Neurosarcoidosis resembling multiple meningiomas: A misleading presentation of the disease and diagnostic challenge
    Acta Radiol Open, 10 (7), 20584601211036550
    DOI 10.1177/20584601211036550, PubMed 34377543
20. Toussaint L, Brandal P, Embring A, Engellau J, Evensen ME, Griskeviskius R, Hansen J, Hietala H, Wickart Johansson G, Jørgensen M, Kramer PH, Kristensen I, Lehtio K, Magelssen H, Maraldo MV, Marienhagen K, Martinsson U, Nilsson K, Peters S, Plaude S, Seiersen K, Sendiuliene D, Smulders B, Edvardsen T, Søbstad JM et al. (2021)
    Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
    Acta Oncol, 61 (2), 235-238
    DOI 10.1080/0284186X.2021.2022202, PubMed 34970940
21. van Eck I, den Hollander D, Lidington E, Hentschel L, Eichler M, Salah S, Singer S, Pinto M, Fauske L, Fiore M, Nixon I, Constantinidou A, Desar IME, Bonenkamp JJ, van Houdt WJ, Reuvers MJP, Haas RLM, Bruland ØS, Kasper B, van der Graaf WTA, Husson O (2021)
    Health-Related Quality of Life Issues Experienced by Thoracic and Breast Sarcoma Patients: A Rare and Understudied Group
    J Clin Med, 10 (22)
    DOI 10.3390/jcm10225334, PubMed 34830615
22. Våde L, Hompland I, Fauske L (2021)
    Exploring Mentorship as a Novel Approach to Improving Quality of Life in Sarcoma Survivors: A Qualitative Pilot Study
    Sarcoma, 2021, 2042785
    DOI 10.1155/2021/2042785, PubMed 34421328

Publications 2020

1. Dagenborg VJ, Marshall SE, Yaqub S, Grzyb K, Boye K, Lund-Iversen M, Høye E, Berstad AE, Fretland ÅA, Edwin B, Ree AH, Flatmark K (2020)
   Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases
   Cancer Biol Ther, 21 (5), 432-440
   DOI 10.1080/15384047.2020.1721252, PubMed 32098573
2. Fauske L, Hompland I, Lorem G, Hall KS, Bondevik H (2020)
   Striving towards Normality in Daily Life: A Qualitative Study of Patients Living with Metastatic Gastrointestinal Stromal Tumour in Long-Term Clinical Remission
   Sarcoma, 2020, 1814394
   DOI 10.1155/2020/1814394, PubMed 33082706
3. Fleten KG, Lund-Andersen C, Waagene S, Abrahamsen TW, Mørch Y, Boye K, Torgunrud A, Flatmark K (2020)
   Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models
   Transl Oncol, 13 (8), 100793
   DOI 10.1016/j.tranon.2020.100793, PubMed 32447231
4. Georgiesh T, Boye K, Bjerkehagen B (2020)
   A novel risk score to predict early and late recurrence in solitary fibrous tumour
   Histopathology, 77 (1), 123-132
   DOI 10.1111/his.14078, PubMed 31991494
5. Hall KS, Bruland ØS, Bjerkehagen B, Lidbrink E, Jebsen N, Hagberg H, Papworth K, Hagberg O, Trovik C, Bauer H, Eriksson M (2020)
   Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study
   Clin Sarcoma Res, 10 (1), 22
   DOI 10.1186/s13569-020-00145-5, PubMed 33292545
6. Hamre CFB, Kvammen EMH, Vinge LE, Skeie AT, Hompland I (2020)
   Sarcoma of the heart
   Tidsskr. Nor. Laegeforen., 140 (6), 582-583
7. Hompland I, Fauske L, Lorem GF, Bruland ØS (2020)
   Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
   Clin Sarcoma Res, 10, 2
   DOI 10.1186/s13569-019-0124-3, PubMed 31969978
8. Janssens GO, Melchior P, Mul J, Saunders D, Bolle S, Cameron AL, Claude L, Gurtner K, van de Ven KP, van Grotel M, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Muracciole X, Boterberg T, Mandeville H, Godzinski J, Graf N, van den Heuvel-Eibrink MM, Rübe C (2020)
   The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy
   Lancet Child Adolesc Health, 4 (11), 846-852
   DOI 10.1016/S2352-4642(20)30183-8, PubMed 33068550
9. König M, Osnes T, Bruland Ø, Sundby Hall K, Bratland Å, Meling TR (2020)
   The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review
   Front Oncol, 10, 1402
   DOI 10.3389/fonc.2020.01402, PubMed 32850452
10. Lachota M, Vincenti M, Winiarska M, Boye K, Zagożdżon R, Malmberg KJ (2020)
    Prospects for NK Cell Therapy of Sarcoma
    Cancers (Basel), 12 (12)
    DOI 10.3390/cancers12123719, PubMed 33322371
11. Napoli E, Stenberg VY, Juzeniene A, Hjellum GE, Bruland ØS, Larsen RH (2020)
    Calibration of sodium iodide detectors and reentrant ionization chambers for ²¹²Pb activity in different geometries by HPGe activity determined samples
    Appl Radiat Isot, 166, 109362
    DOI 10.1016/j.apradiso.2020.109362, PubMed 32979756
12. Palmerini E, Leithner A, Windhager R, Gosheger G, Boye K, Laitinen M, Hardes J, Traub F, Jutte P, Willegger M, Casanova J, Setola E, Righi A, Picci P, Donati DM, Ferrari S (2020)
    Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS)
    Sci Rep, 10 (1), 10853
    DOI 10.1038/s41598-020-66579-5, PubMed 32616718
13. Radaelli S, Fossati P, Stacchiotti S, Akiyama T, Asencio JM, Bandiera S, Boglione A, Boland P, Bolle S, Bruland Ø, Brunello A, Bruzzi P, Campanacci D, Cananzi F, Capanna R, Casadei R, Cordoba A, Court C, Dei Tos AP, DeLaney TF, De Paoli A, De Pas TM, Desai A, Di Brina L, Donati DM et al. (2020)
    The sacral chordoma margin
    Eur J Surg Oncol, 46 (8), 1415-1422
    DOI 10.1016/j.ejso.2020.04.028, PubMed 32402509
14. Ree AH, Nygaard V, Boye K, Heinrich D, Dueland S, Bergheim IR, Johansen C, Beiske K, Negård A, Lund-Iversen M, Nygaard V, Hovig E, Nakken S, Nasser S, Julsrud L, Reisse CH, Ruud EA, Kristensen VN, Flørenes VA, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Russnes HG, Mælandsmo GM, Flatmark K (2020)
    Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study
    Acta Oncol, 59 (7), 733-740
    DOI 10.1080/0284186X.2020.1742377, PubMed 32208873
15. Stenberg VY, Juzeniene A, Bruland ØS, Larsen RH (2020)
    In situ Generated ²¹²Pb-PSMA Ligand in a ²²⁴Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
    Curr Radiopharm, 13 (2), 130-141
    DOI 10.2174/1874471013666200511000532, PubMed 32389119
16. Stenberg VY, Juzeniene A, Chen Q, Yang X, Bruland ØS, Larsen RH (2020)
    Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [²¹² Pb]Pb-NG001 for prostate cancer
    J Labelled Comp Radiopharm, 63 (3), 129-143
    DOI 10.1002/jlcr.3825, PubMed 31919866

Publications 2019

1. Berner K, Bruland ØS (2019)
   Prognostic Impact of Proximal Versus Distal Localization in Extremity Long Bone Osteosarcomas
   Anticancer Res, 39 (5), 2459-2466
   DOI 10.21873/anticanres.13365, PubMed 31092440
2. Fauske L, Bondevik H, Ahlberg K, Bjørndal A (2019)
   Identifying bone sarcoma survivors facing psychosocial challenges. A study of trajectories following treatment
   Eur J Cancer Care (Engl), 28 (5), e13119
   DOI 10.1111/ecc.13119, PubMed 31184795
3. Fauske L, Hompland I, Lorem G, Bondevik H, Bruland ØS (2019)
   Perspectives on treatment side effects in patients with metastatic gastrointestinal stromal tumour: a qualitative study
   Clin Sarcoma Res, 9, 6
   DOI 10.1186/s13569-019-0116-3, PubMed 31061697
4. Hoeben BA, Carrie C, Timmermann B, Mandeville HC, Gandola L, Dieckmann K, Ramos Albiac M, Magelssen H, Lassen-Ramshad Y, Ondrová B, Ajithkumar T, Alapetite C, Balgobind BV, Bolle S, Cameron AL, Davila Fajardo R, Dietzsch S, Dumont Lecomte D, van den Heuvel-Eibrink MM, Kortmann RD, Laprie A, Melchior P, Padovani L, Rombi B, Scarzello G et al. (2019)
   Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group
   Lancet Oncol, 20 (3), e155-e166
   DOI 10.1016/S1470-2045(19)30034-8, PubMed 30842059
5. Hølmebakk T, Bjerkehagen B, Lobmaier IVK, Hompland I, Stoldt S, Boye K (2019)
   Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors?
   Ann Surg Oncol, 26 (13), 4730-4736
   DOI 10.1245/s10434-019-07813-x, PubMed 31520212
6. Jha AK, Neupane P, Pradhan M, Sharma KS, Shrestha S, Sigdel PR, Smeland S, Bruland ØS (2019)
   Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy
   J Glob Oncol, 5, 1-10
   DOI 10.1200/JGO.19.00015, PubMed 30917070
7. Köksal H, Müller E, Inderberg EM, Bruland Ø, Wälchli S (2019)
   Treating osteosarcoma with CAR T cells
   Scand J Immunol, 89 (3), e12741
   DOI 10.1111/sji.12741, PubMed 30549299
8. Namløs HM, Boye K, Meza-Zepeda LA (2019)
   Cell-free DNA in blood as a noninvasive insight into the sarcoma genome
   Mol Aspects Med, 72, 100827
   DOI 10.1016/j.mam.2019.10.004, PubMed 31703948
9. Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP (2019)
   Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy
   Acta Oncol, 58 (10), 1416-1422
   DOI 10.1080/0284186X.2019.1643496, PubMed 31364899
10. Thorkildsen J, Taksdal I, Bjerkehagen B, Haugland HK, Børge Johannesen T, Viset T, Norum OJ, Bruland Ø, Zaikova O (2019)
    Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort
    Acta Oncol, 58 (3), 273-282
    DOI 10.1080/0284186X.2018.1554260, PubMed 30632866

Publications 2018

1. Ajithkumar T, Horan G, Padovani L, Thorp N, Timmermann B, Alapetite C, Gandola L, Ramos M, Van Beek K, Christiaens M, Lassen-Ramshad Y, Magelssen H, Nilsson K, Saran F, Rombi B, Kortmann R, Janssens GO, SIOPE BTG Radiotherapy Group (2018)
   SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy
   Radiother Oncol, 128 (2), 192-197
   DOI 10.1016/j.radonc.2018.04.016, PubMed 29729847
2. Berner K, Johannesen TB, Hall KS, Bruland ØS (2018)
   Clinical epidemiology and treatment outcomes of spindle cell non-osteogenic bone sarcomas - A nationwide population-based study
   J Bone Oncol, 14, 002-2
   DOI 10.1016/j.jbo.2018.11.002, PubMed 30568874
3. Berner K, Zaikova O, Johannesen TB, Hall KS, Bruland ØS (2018)
   Validity and completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway
   J Surg Oncol, 118 (1), 246-247
   DOI 10.1002/jso.25137, PubMed 30208205
4. Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K, Bjerkehagen B, Hølmebakk T (2018)
   Genotype and risk of tumour rupture in gastrointestinal stromal tumour
   Br J Surg, 105 (2), e169-e175
   DOI 10.1002/bjs.10743, PubMed 29341147
5. Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R, Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A, Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P et al. (2018)
   Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series
   JAMA Oncol, 4 (9), e180219
   DOI 10.1001/jamaoncol.2018.0219, PubMed 29800950
6. Heinrich D, Bruland Ø, Guise TA, Suzuki H, Sartor O (2018)
   Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker
   Future Oncol, 14 (24), 2543-2556
   DOI 10.2217/fon-2018-0087, PubMed 29925281
7. Hesla AC, Bruland ØS, Jebsen N, Styring E, Eriksson S, Tsagozis P (2018)
   Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years
   J Bone Oncol, 14, 100216
   DOI 10.1016/j.jbo.2018.100216, PubMed 30666289
8. Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K (2018)
   Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour
   Br J Surg, 106 (4), 419-426
   DOI 10.1002/bjs.11027, PubMed 30507040
9. Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K (2018)
   Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study
   Ann Surg Oncol, 25 (5), 1133-1139
   DOI 10.1245/s10434-018-6353-5, PubMed 29435684
10. Johnsen B, Fasmer KE, Boye K, Rosendahl K, Trovik C, Biermann M, Aukland SM (2018)
    Added value of F-18-FDG PET-CT in staging of Ewing sarcoma in children and young adults
    Eur. J. Hybrid Imag., 2 (1), 13
    DOI 10.1186/s41824-018-0031-5
11. Longhi A, Paioli A, Palmerini E, Cesari M, Abate ME, Setola E, Spinnato P, Donati D, Hompland I, Boye K (2018)
    Pazopanib in relapsed osteosarcoma patients: report on 15 cases
    Acta Oncol, 58 (1), 124-128
    DOI 10.1080/0284186X.2018.1503714, PubMed 30207179
12. Namløs HM, Boye K, Mishkin SJ, Barøy T, Lorenz S, Bjerkehagen B, Stratford EW, Munthe E, Kudlow BA, Myklebost O, Meza-Zepeda LA (2018)
    Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor
    Mol Cancer Ther, 17 (11), 2473-2480
    DOI 10.1158/1535-7163.MCT-18-0174, PubMed 30097488
13. Seravalli E, Bosman M, Lassen-Ramshad Y, Vestergaard A, Oldenburger F, Visser J, Koutsouveli E, Paraskevopoulou C, Horan G, Ajithkumar T, Timmermann B, Fuentes CS, Whitfield G, Marchant T, Padovani L, Garnier E, Gandola L, Meroni S, Hoeben BAW, Kusters M, Alapetite C, Losa S, Goudjil F, Magelssen H, Evensen ME et al. (2018)
    Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group)
    Acta Oncol, 57 (9), 1240-1249
    DOI 10.1080/0284186X.2018.1465588, PubMed 29698060
14. Sundby Hall K, Bruland ØS, Bjerkehagen B, Zaikova O, Engellau J, Hagberg O, Hansson L, Hagberg H, Ahlström M, Knobel H, Papworth K, Zemmler M, Goplen D, Bauer HCF, Eriksson M (2018)
    Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX)
    Eur J Cancer, 99, 78-85
    DOI 10.1016/j.ejca.2018.05.011, PubMed 29929092
15. Westrøm S, Bønsdorff TB, Bruland ØS, Larsen RH (2018)
    Therapeutic Effect of α-Emitting ²²⁴Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer
    Transl Oncol, 11 (2), 259-267
    DOI 10.1016/j.tranon.2017.12.011, PubMed 29413758
16. Westrøm S, Malenge M, Jorstad IS, Napoli E, Bruland ØS, Bønsdorff TB, Larsen RH (2018)
    Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice
    J Labelled Comp Radiopharm, 61 (6), 472-486
    DOI 10.1002/jlcr.3610, PubMed 29380410

Publications 2017

1. Boye K, Jebsen NL, Zaikova O, Knobel H, Løndalen AM, Trovik CS, Monge OR, Hall KS (2017)
   Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort
   Acta Oncol, 56 (3), 479-483
   DOI 10.1080/0284186X.2016.1278305, PubMed 28105885
2. Egeland EV, Boye K, Park D, Synnestvedt M, Sauer T, Oslo Breast Cancer Consortium (OSBREAC), Naume B, Borgen E, Mælandsmo GM (2017)
   Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer
   Breast Cancer Res Treat, 162 (1), 127-137
   DOI 10.1007/s10549-016-4096-1, PubMed 28058579
3. Hompland I, Bruland ØS, Hølmebakk T, Poulsen JP, Stoldt S, Hall KS, Boye K (2017)
   Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort
   Acta Oncol, 56 (10), 1317-1323
   DOI 10.1080/0284186X.2017.1330555, PubMed 28557540
4. Namløs HM, Zaikova O, Bjerkehagen B, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2017)
   Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report
   BMC Cancer, 17 (1), 29
   DOI 10.1186/s12885-016-2992-8, PubMed 28061772
5. Parker CC, Coleman RE, Sartor O, Vogelzang NJ, Bottomley D, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Bruland ØS et al. (2017)
   Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial
   Eur Urol, 73 (3), 427-435
   DOI 10.1016/j.eururo.2017.06.021, PubMed 28705540
6. Pulkka OP, Nilsson B, Sarlomo-Rikala M, Reichardt P, Eriksson M, Hall KS, Wardelmann E, Vehtari A, Joensuu H, Sihto H (2017)
   SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour
   Br J Cancer, 116 (9), 1195-1202
   DOI 10.1038/bjc.2017.82, PubMed 28334729
7. Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA et al. (2017)
   Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
   ESMO Open, 2 (2), e000158
   DOI 10.1136/esmoopen-2017-000158, PubMed 28761742
8. Sartor O, Coleman RE, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Vogelzang NJ, Bruland Ø, Kobina S, Wilhelm S, Xu L, Shan M, Kattan MW, Parker C (2017)
   An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223
   Ann Oncol, 28 (5), 1090-1097
   DOI 10.1093/annonc/mdx044, PubMed 28453701
9. Stacchiotti S, Mir O, Le Cesne A, Vincenzi B, Fedenko A, Maki RG, Somaiah N, Patel S, Brahmi M, Blay JY, Boye K, Sundby Hall K, Gelderblom H, Hindi N, Martin-Broto J, Kosela H, Rutkowski P, Italiano A, Duffaud F, Kobayashi E, Casali PG, Provenzano S, Kawai A (2017)
   Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma
   Oncologist, 23 (1), 62-70
   DOI 10.1634/theoncologist.2017-0161, PubMed 28754721

Publications 2016

1. Barøy T, Chilamakuri CS, Lorenz S, Sun J, Bruland ØS, Myklebost O, Meza-Zepeda LA (2016)
   Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene
   PLoS One, 11 (9), e0163859
   DOI 10.1371/journal.pone.0163859, PubMed 27685995
2. Boye K, Jacob H, Frikstad KA, Nesland JM, Maelandsmo GM, Dahl O, Nesbakken A, Flatmark K (2016)
   Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy
   Cancer Med, 5 (8), 1840-9
   DOI 10.1002/cam4.766, PubMed 27273130
3. Egeland EV, Flatmark K, Nesland JM, Flørenes VA, Mælandsmo GM, Boye K (2016)
   Expression and clinical significance of Wee1 in colorectal cancer
   Tumour Biol, 37 (9), 12133-12140
   DOI 10.1007/s13277-016-5081-3, PubMed 27220319
4. Hompland I, Bruland ØS, Ubhayasekhera K, Bergquist J, Boye K (2016)
   Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour
   Clin Sarcoma Res, 6, 21
   DOI 10.1186/s13569-016-0062-2, PubMed 27999655
5. Johnsen B, Fasmer KE, Boye K, Rosendahl K, Trovik C, Biermann M, Aukland SM (2016)
   Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012
   Pediatr Radiol, 47 (1), 82-88
   DOI 10.1007/s00247-016-3720-x, PubMed 27815616
6. Kongsgaard A, Boye K, Fodstad Ø, Juell S, Jørgensen LH, Solberg S, Helland Å, Brustugun OT, Mælandsmo GM (2016)
   Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer
   Diagn Pathol, 11 (1), 50
   DOI 10.1186/s13000-016-0504-4, PubMed 27316334
7. König M, Osnes TA, Lobmaier I, Bjerkehagen B, Bruland ØS, Sundby Hall K, Meling TR (2016)
   Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years
   Neurosurg Rev, 40 (3), 449-460
   DOI 10.1007/s10143-016-0802-z, PubMed 27858303
8. Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS et al. (2016)
   Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
   Lancet Oncol, 17 (10), 1396-1408
   DOI 10.1016/S1470-2045(16)30214-5, PubMed 27569442
9. Parker C, Finkelstein SE, Michalski JM, O'Sullivan JM, Bruland Ø, Vogelzang NJ, Coleman RE, Nilsson S, Sartor O, Li R, Seger MA, Bottomley D (2016)
   Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial
   Eur Urol, 70 (5), 875-883
   DOI 10.1016/j.eururo.2016.06.002, PubMed 27344296
10. Varghese M, Bruland O, Wiedswang AM, Lobmaier I, Røsok B, Benjamin RS, Hall KS (2016)
    Metastatic mesenteric dedifferentiated leiomyosarcoma: a case report and a review of literature
    Clin Sarcoma Res, 6, 2
    DOI 10.1186/s13569-016-0042-6, PubMed 26913180
11. Westrøm S, Bønsdorff TB, Abbas N, Bruland ØS, Jonasdottir TJ, Mælandsmo GM, Larsen RH (2016)
    Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma
    PLoS One, 11 (10), e0165382
    DOI 10.1371/journal.pone.0165382, PubMed 27776176

Publications 2015

1. Anfinsen KP, Grotmol T, Bruland OS, Cathrine T, Jonasdottir TJ (2015)
   Corrigendum to "Primary bone cancer in Leonbergers may be associated with a higher bodyweight during adolescence" [Prev. Vet. Med. 119 (2015) 48-53]
   Prev Vet Med, 120 (2), 252
   DOI 10.1016/j.prevetmed.2015.03.015, PubMed 31159133
2. Anfinsen KP, Grotmol T, Bruland OS, Trangerud C, Jonasdottir TJ (2015)
   Primary bone cancer in Leonbergers may be associated with a higher bodyweight during adolescence
   Prev Vet Med, 119 (1-2), 48-53
   DOI 10.1016/j.prevetmed.2015.02.003, PubMed 25732913
3. Berner K, Bjerkehagen B, Bruland ØS, Berner A (2015)
   Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature
   Anticancer Res, 35 (4), 2129-40
   PubMed 25862869
4. Berner K, Hall KS, Monge OR, Weedon-Fekjær H, Zaikova O, Bruland ØS (2015)
   Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient
   Sarcoma, 2015, 516843
   DOI 10.1155/2015/516843, PubMed 25784831
5. Berner K, Johannesen TB, Bruland ØS (2015)
   Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009
   Sarcoma, 2015, 917679
   DOI 10.1155/2015/917679, PubMed 26412976
6. Egeland EV, Boye K, Pettersen SJ, Haugen MH, Øyjord T, Malerød L, Flatmark K, Mælandsmo GM (2015)
   Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes
   Clin Exp Metastasis, 32 (8), 755-67
   DOI 10.1007/s10585-015-9742-1, PubMed 26349943
7. Fauske L, Bondevik H, Bruland ØS, Ozakinci G (2015)
   Negative and Positive Consequences of Cancer Treatment Experienced by Long-term Osteosarcoma Survivors: A Qualitative Study
   Anticancer Res, 35 (11), 6081-90
   PubMed 26504033
8. Fauske L, Bruland OS, Grov EK, Bondevik H (2015)
   Cured of primary bone cancer, but at what cost: a qualitative study of functional impairment and lost opportunities
   Sarcoma, 2015, 484196
   DOI 10.1155/2015/484196, PubMed 25949211
9. Fauske L, Lorem G, Grov EK, Bondevik H (2015)
   Changes in the body image of bone sarcoma survivors following surgical treatment--A qualitative study
   J Surg Oncol, 113 (2), 229-34
   DOI 10.1002/jso.24138, PubMed 26714610
10. Ferrari S, Luksch R, Hall KS, Fagioli F, Prete A, Tamburini A, Tienghi A, DiGirolamo S, Paioli A, Abate ME, Podda M, Cammelli S, Eriksson M, Brach del Prever A (2015)
    Post-relapse survival in patients with Ewing sarcoma
    Pediatr Blood Cancer, 62 (6), 994-9
    DOI 10.1002/pbc.25388, PubMed 25585917
11. Hompland I, Bruland ØS (2015)
    Can Imatinib Be Safely Withdrawn in Patients with Surgically Resected Metastatic GIST?
    Anticancer Res, 35 (11), 5759-65
    PubMed 26503996
12. Hompland I, Rizvi SM, Winge M, Norum OJ, Bjerkehagen B, Ringen HO, Taksdal I, Mørk NJ, Hall KS (2015)
    [A boy with a wound on his finger that would not heal]
    Tidsskr Nor Laegeforen, 135 (5), 445-8
    DOI 10.4045/tidsskr.14.0759, PubMed 25761032
13. Hompland I, Rizvi SMH, Winge M, Norum OJ, Bjerkehagen B, Ringen HO, Taksdal I, Mork NJ, Hall KS (2015)
    A boy with a wound on his finger that would not heal
    Tidsskr. Nor. Laegeforen., 135 (5), 444-447
14. Humm JL, Sartor O, Parker C, Bruland OS, Macklis R (2015)
    Radium-223 in the treatment of osteoblastic metastases: a critical clinical review
    Int J Radiat Oncol Biol Phys, 91 (5), 898-906
    DOI 10.1016/j.ijrobp.2014.12.061, PubMed 25832684
15. Johnsen B, Boye K, Rosendahl K, Biermann M, Trovik C, Aukland SM (2015)
    F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study
    Clin Physiol Funct Imaging, 36 (6), 441-446
    DOI 10.1111/cpf.12247, PubMed 26039107
16. Juzeniene A, Baturaite Z, Lagunova Z, Grigalavicius M, Porojnicu AC, Bruland ØS, Moan J (2015)
    Influence of multiple UV exposures on serum cobalamin and vitamin D levels in healthy females
    Scand J Public Health, 43 (3), 324-30
    DOI 10.1177/1403494815572206, PubMed 25740614
17. Juzeniene A, Porojnicu AC, Baturaite Z, Lagunova Z, Aksnes L, Bruland ØS, Moan J (2015)
    Vitamin D levels and dietary intake among patients with benign soft tissue tumors and sarcomas
    Anticancer Res, 35 (2), 1171-80
    PubMed 25667508
18. Kolberg M, Høland M, Lind GE, Ågesen TH, Skotheim RI, Hall KS, Mandahl N, Smeland S, Mertens F, Davidson B, Lothe RA (2015)
    Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection
    Mol Oncol, 9 (6), 1129-39
    DOI 10.1016/j.molonc.2015.02.005, PubMed 25769404
19. Prasmickaite L, Berge G, Bettum IJ, Aamdal S, Hansson J, Bastholt L, Øijordsbakken M, Boye K, Mælandsmo GM (2015)
    Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial
    Cancer Immunol Immunother, 64 (6), 769-76
    DOI 10.1007/s00262-015-1686-4, PubMed 25832001

Publications 2014

1. Berner K, Johannesen TB, Berner A, Haugland HK, Bjerkehagen B, Bøhler PJ, Bruland ØS (2014)
   Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma
   Acta Oncol, 54 (1), 25-33
   DOI 10.3109/0284186X.2014.923934, PubMed 24957555
2. Haugen MH, Boye K, Nesland JM, Pettersen SJ, Egeland EV, Tamhane T, Brix K, Maelandsmo GM, Flatmark K (2014)
   High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting
   Eur J Cancer, 51 (1), 9-17
   DOI 10.1016/j.ejca.2014.10.020, PubMed 25466510
3. Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K, Fodstad Ø (2014)
   B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
   BMC Cancer, 14, 602
   DOI 10.1186/1471-2407-14-602, PubMed 25139714
4. Joensuu H, Eriksson M, Hall KS, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Ballman KV, Leinonen M, DeMatteo RP, Reichardt P (2014)
   Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
   Cancer, 120 (15), 2325-33
   DOI 10.1002/cncr.28669, PubMed 24737415
5. Ohnstad HO, Bruland OS, Taksdal I, Bjerkehagen B, Nenadovic M, Sæter G, Jørgensen LH, Hall KS (2014)
   Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma - a predictor of outcome?
   Acta Oncol, 53 (9), 1180-7
   DOI 10.3109/0284186X.2014.899433, PubMed 24697744
6. Panagopoulos I, Bjerkehagen B, Gorunova L, Berner JM, Boye K, Heim S (2014)
   Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification
   Int J Oncol, 45 (5), 1829-36
   DOI 10.3892/ijo.2014.2605, PubMed 25176350
7. Panagopoulos I, Gorunova L, Bjerkehagen B, Boye K, Heim S (2014)
   Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma
   Oncol Rep, 32 (1), 40-4
   DOI 10.3892/or.2014.3180, PubMed 24839999
8. Repetto-Llamazares A, Abbas N, Bruland ØS, Dahle J, Larsen RH (2014)
   Advantage of lutetium-177 versus radioiodine immunoconjugate in targeted radionuclide therapy of b-cell tumors
   Anticancer Res, 34 (7), 3263-9
   PubMed 24982330
9. Repetto-Llamazares AH, Larsen RH, Giusti AM, Riccardi E, Bruland ØS, Selbo PK, Dahle J (2014)
   177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice
   PLoS One, 9 (7), e103070
   DOI 10.1371/journal.pone.0103070, PubMed 25068508
10. Sartor O, Coleman R, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Vogelzang NJ, O'Bryan-Tear CG, Shan M, Bruland ØS, Parker C (2014)
    Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
    Lancet Oncol, 15 (7), 738-46
    DOI 10.1016/S1470-2045(14)70183-4, PubMed 24836273
11. Switlyk MD, Bruland ØS, Skjeldal S, Hald JK, Seierstad T, Zaikova O (2014)
    Radiotherapy for spinal metastases from breast cancer with emphasis on local disease control and pain response using repeated MRI
    J Bone Oncol, 3 (1), 5-9
    DOI 10.1016/j.jbo.2014.02.003, PubMed 26909292

Publications 2013

1. Abbas N, Heyerdahl H, Bruland ØS, Brevik EM, Dahle J (2013)
   Comparing high LET 227Th- and low LET 177Lu-trastuzumab in mice with HER-2 positive SKBR-3 xenografts
   Curr Radiopharm, 6 (2), 78-86
   DOI 10.2174/18744710113069990017, PubMed 23551110
2. Bjerkehagen B, Småstuen MC, Hall KS, Skjeldal S, Bruland ØS, Smeland S, Johannesen TB, Fosså SD (2013)
   Incidence and mortality of second sarcomas - a population-based study
   Eur J Cancer, 49 (15), 3292-302
   DOI 10.1016/j.ejca.2013.05.017, PubMed 23787025
3. Boye K, Del Prever AB, Eriksson M, Saeter G, Tienghi A, Lindholm P, Fagioli F, Skjeldal S, Ferrari S, Hall KS (2013)
   High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study
   Pediatr Blood Cancer, 61 (5), 840-5
   DOI 10.1002/pbc.24868, PubMed 24254749
4. Dahle J, Repetto-Llamazares AH, Mollatt CS, Melhus KB, Bruland OS, Kolstad A, Larsen RH (2013)
   Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphoma
   Anticancer Res, 33 (1), 85-95
   PubMed 23267131
5. Friedman R, Boye K, Flatmark K (2013)
   Molecular modelling and simulations in cancer research
   Biochim Biophys Acta, 1836 (1), 1-14
   DOI 10.1016/j.bbcan.2013.02.001, PubMed 23416097
6. Heyerdahl H, Abbas N, Sponheim K, Mollatt C, Bruland Ø, Dahle J (2013)
   Targeted alpha therapy with 227Th-trastuzumab of intraperitoneal ovarian cancer in nude mice
   Curr Radiopharm, 6 (2), 106-16
   DOI 10.2174/18744710113069990018, PubMed 23551111
7. Håvik AB, Lind GE, Honne H, Meling TR, Scheie D, Hall KS, van den Berg E, Mertens F, Picci P, Lothe RA, Heim S, Brandal P (2013)
   Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors
   Neuro Oncol, 16 (2), 320-2
   DOI 10.1093/neuonc/not230, PubMed 24311631
8. Jebsen NL, Engellau J, Engström K, Bauer HC, Monge OR, Muren LP, Eide GE, Trovik CS, Bruland OS (2013)
   Patterns of local recurrence and dose fractionation of adjuvant radiation therapy in 462 patients with soft tissue sarcoma of extremity and trunk wall
   Int J Radiat Oncol Biol Phys, 86 (5), 949-55
   DOI 10.1016/j.ijrobp.2013.04.015, PubMed 23725998
9. Kongsgaard A, Boye K, Oijordsbakken M, Lund-Iversen M, Halvorsen AR, Solberg SK, Berge G, Helland A, Brustugun OT, Mælandsmo GM (2013)
   Osteopontin is a prognostic biomarker in non-small cell lung cancer
   BMC Cancer, 13, 540
   DOI 10.1186/1471-2407-13-540, PubMed 24215488
10. Lagunova Z, Porojnicu AC, Aksnes L, Holick MF, Iani V, Bruland OS, Moan J (2013)
    Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trial
    Br J Dermatol, 169 (2), 434-40
    DOI 10.1111/bjd.12349, PubMed 23551243
11. Lia K, Bruland ØS, Randem HL, Aksnes LH, Poulsen JP, Taksdal I, Sundby Hall K (2013)
    Two cases with fatal outcome following total lung irradiation for metastatic bone sarcoma
    J Bone Oncol, 2 (4), 174-9
    DOI 10.1016/j.jbo.2013.09.002, PubMed 26909289
12. Mikalsen LT, Dhakal HP, Bruland ØS, Naume B, Borgen E, Nesland JM, Olsen DR (2013)
    The clinical impact of mean vessel size and solidity in breast carcinoma patients
    PLoS One, 8 (10), e75954
    DOI 10.1371/journal.pone.0075954, PubMed 24146798
13. Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG et al. (2013)
    Alpha emitter radium-223 and survival in metastatic prostate cancer
    N Engl J Med, 369 (3), 213-23
    DOI 10.1056/NEJMoa1213755, PubMed 23863050
14. Revheim ME, Hole KH, Bruland OS, Reitan E, Bjerkehagen B, Julsrud L, Seierstad T (2013)
    Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
    Acta Oncol, 53 (1), 143-8
    DOI 10.3109/0284186X.2013.798428, PubMed 23710697
15. Revheim ME, Kristian A, Malinen E, Bruland ØS, Berner JM, Holm R, Joensuu H, Seierstad T (2013)
    Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
    Acta Oncol, 52 (4), 776-82
    DOI 10.3109/0284186X.2013.770920, PubMed 23480638
16. Rusten E, Rødal J, Bruland Ø, Malinen E (2013)
    Biologic targets identified from dynamic 18FDG-PET and implications for image-guided therapy
    Acta Oncol, 52 (7), 1378-83
    DOI 10.3109/0284186X.2013.813071, PubMed 23981046

Publications 2012

1. Abbas N, Bruland ØS, Brevik EM, Dahle J (2012)
   Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts
   Nucl Med Commun, 33 (8), 838-47
   DOI 10.1097/MNM.0b013e328354df7c, PubMed 22643311
2. Holmboe L, Andersen AM, Mørkrid L, Slørdal L, Hall KS (2012)
   High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
   Br J Clin Pharmacol, 73 (1), 106-14
   DOI 10.1111/j.1365-2125.2011.04054.x, PubMed 21707700
3. Haas RL, Delaney TF, O'Sullivan B, Keus RB, Le Pechoux C, Olmi P, Poulsen JP, Seddon B, Wang D (2012)
   Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?
   Int J Radiat Oncol Biol Phys, 84 (3), 572-80
   DOI 10.1016/j.ijrobp.2012.01.062, PubMed 22520481
4. Ingebrigtsen VA, Boye K, Tekle C, Nesland JM, Flatmark K, Fodstad O (2012)
   B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer
   Int J Cancer, 131 (11), 2528-36
   DOI 10.1002/ijc.27566, PubMed 22473715
5. Kolberg M, Høland M, Agesen TH, Brekke HR, Liestøl K, Hall KS, Mertens F, Picci P, Smeland S, Lothe RA (2012)
   Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
   Neuro Oncol, 15 (2), 135-47
   DOI 10.1093/neuonc/nos287, PubMed 23161774
6. Kongsgaard A, Lund-Iversen M, Berge G, Brustugun OT, Solberg SK, Mælandsmo GM, Boye K (2012)
   Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
   BMC Cancer, 12, 333
   DOI 10.1186/1471-2407-12-333, PubMed 22853000
7. Micu E, Baturaite Z, Juzeniene A, Bruland ØS, Moan JE (2012)
   Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients
   Melanoma Res, 22 (6), 460-5
   DOI 10.1097/CMR.0b013e3283599cc3, PubMed 23010822
8. Namløs HM, Kresse SH, Müller CR, Henriksen J, Holdhus R, Sæter G, Bruland OS, Bjerkehagen B, Steen VM, Myklebost O (2012)
   Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern
   Sarcoma, 2012, 639038
   DOI 10.1155/2012/639038, PubMed 22518090
9. Nilsson S, Franzén L, Parker C, Tyrrell C, Blom R, Tennvall J, Lennernäs B, Petersson U, Johannessen DC, Sokal M, Pigott K, O'Bryan-Tear CG, Thuresson M, Bolstad B, Bruland ØS (2012)
   Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases
   Clin Genitourin Cancer, 11 (1), 20-6
   DOI 10.1016/j.clgc.2012.07.002, PubMed 23021204
10. Nilsson S, Strang P, Aksnes AK, Franzèn L, Olivier P, Pecking A, Staffurth J, Vasanthan S, Andersson C, Bruland ØS (2012)
    A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
    Eur J Cancer, 48 (5), 678-86
    DOI 10.1016/j.ejca.2011.12.023, PubMed 22341993
11. Rusten E, Rødal J, Revheim ME, Skretting A, Bruland OS, Malinen E (2012)
    Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas
    Acta Oncol, 52 (6), 1160-7
    DOI 10.3109/0284186X.2012.728713, PubMed 23198721
12. Sartor O, Hoskin P, Bruland OS (2012)
    Targeted radio-nuclide therapy of skeletal metastases
    Cancer Treat Rev, 39 (1), 18-26
    DOI 10.1016/j.ctrv.2012.03.006, PubMed 22534284
13. Schee K, Boye K, Abrahamsen TW, Fodstad Ø, Flatmark K (2012)
    Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
    BMC Cancer, 12, 505
    DOI 10.1186/1471-2407-12-505, PubMed 23121918
14. Schee K, Flatmark K, Holm R, Boye K, Paus E (2012)
    Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients (vol 33, pg 73, 2012)
    Tumor Biol., 33 (4), 1263-1264
    DOI 10.1007/s13277-012-0407-2

Publications 2011

1. Abbas N, Heyerdahl H, Bruland OS, Borrebæk J, Nesland J, Dahle J (2011)
   Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab
   EJNMMI Res, 1 (1), 18
   DOI 10.1186/2191-219X-1-18, PubMed 22214432
2. Anfinsen KP, Devesa SS, Bray F, Troisi R, Jonasdottir TJ, Bruland OS, Grotmol T (2011)
   Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976-2005)
   Cancer Epidemiol Biomarkers Prev, 20 (8), 1770-7
   DOI 10.1158/1055-9965.EPI-11-0136, PubMed 21724855
3. Anfinsen KP, Grotmol T, Bruland OS, Jonasdottir TJ (2011)
   Breed-specific incidence rates of canine primary bone tumors--a population based survey of dogs in Norway
   Can J Vet Res, 75 (3), 209-15
   PubMed 22210997
4. Berge G, Pettersen S, Grotterød I, Bettum IJ, Boye K, Mælandsmo GM (2011)
   Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis
   Int J Cancer, 129 (4), 780-90
   DOI 10.1002/ijc.25735, PubMed 20957651
5. Dahle J, Abbas N, Bruland ØS, Larsen RH (2011)
   Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates
   Curr Radiopharm, 4 (4), 321-8
   DOI 10.2174/1874471011104040321, PubMed 22202154
6. Mikalsen LT, Dhakal HP, Bruland OS, Nesland JM, Olsen DR (2011)
   Quantification of angiogenesis in breast cancer by automated vessel identification in CD34 immunohistochemical sections
   Anticancer Res, 31 (12), 4053-60
   PubMed 22199261
7. Revheim ME, Røe K, Bruland ØS, Bach-Gansmo T, Skretting A, Seierstad T (2011)
   Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT
   Mol Imaging Biol, 13 (6), 1234-40
   DOI 10.1007/s11307-010-0464-0, PubMed 21161686
8. Sartor O, Bruland O (2011)
   Stromal targeted therapies in prostate and renal cancer: new concepts and knowledge
   Clin Genitourin Cancer, 9 (1), 1-2
   DOI 10.1016/j.clgc.2011.08.001, PubMed 21925102
9. Sartor O, Goeckeler W, Bruland O (2011)
   Stromal targeted therapy in bone metastatic prostate cancer: promise delivered
   Asian J Androl, 13 (6), 783-4
   DOI 10.1038/aja.2011.120, PubMed 21857688
10. Schee K, Flatmark K, Holm R, Boye K, Paus E (2011)
    Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
    Tumour Biol, 33 (1), 73-83
    DOI 10.1007/s13277-011-0247-5, PubMed 22006279
11. Smeland S, Bruland OS, Hjorth L, Brosjö O, Bjerkehagen B, Osterlundh G, Jakobson A, Hall KS, Monge OR, Björk O, Alvegaard TA (2011)
    Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years
    Acta Orthop, 82 (2), 211-6
    DOI 10.3109/17453674.2011.566141, PubMed 21434784
12. Stensvold E, Magelssen H, Oskam IC (2011)
    Fertility-preserving measures for girls and young women with cancer
    Tidsskr Nor Laegeforen, 131 (15), 1429-32
    DOI 10.4045/tidsskr.11.0126, PubMed 21844944
13. Stensvold E, Magelssen H, Oskam IC (2011)
    Fertility-preserving measures for boys and young men with cancer
    Tidsskr Nor Laegeforen, 131 (15), 1433-5
    DOI 10.4045/tidsskr.11.0426, PubMed 21844945
14. Zaikova O, Fosså SD, Bruland OS, Giercksky KE, Sandstad B, Skjeldal S (2011)
    Radiotherapy or surgery for spine metastases?
    Acta Orthop, 82 (3), 365-71
    DOI 10.3109/17453674.2011.566142, PubMed 21434789

Publications 2010

1. Brekke HR, Ribeiro FR, Kolberg M, Agesen TH, Lind GE, Eknaes M, Hall KS, Bjerkehagen B, van den Berg E, Teixeira MR, Mandahl N, Smeland S, Mertens F, Skotheim RI, Lothe RA (2010)
   Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group
   J Clin Oncol, 28 (9), 1573-82
   DOI 10.1200/JCO.2009.24.8989, PubMed 20159821
2. Cicarma E, Juzeniene A, Porojnicu AC, Bruland ØS, Moan J (2010)
   Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007
   J Photochem Photobiol B, 101 (2), 174-8
   DOI 10.1016/j.jphotobiol.2010.04.002, PubMed 20430639
3. Dale E, Hårsaker V, Kristoffersen DT, Bruland O, Olsen DR (2010)
   CT density in lung cancer patients after radiotherapy sensitized by metoclopramide. A subgroup analysis of a randomized trial
   Strahlenther Onkol, 186 (3), 163-8
   DOI 10.1007/s00066-010-2040-6, PubMed 20165821
4. Grotterød I, Maelandsmo GM, Boye K (2010)
   Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB
   BMC Cancer, 10, 241
   DOI 10.1186/1471-2407-10-241, PubMed 20507646
5. Jebsen NL, Bruland ØS, Eriksson M, Engellau J, Turesson I, Folin A, Trovik CS, Hall KS (2010)
   Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall
   Int J Radiat Oncol Biol Phys, 81 (5), 1359-66
   DOI 10.1016/j.ijrobp.2010.07.037, PubMed 20933339
6. König M, Mork J, Hall KS, Osnes T, Meling TR (2010)
   Multimodal treatment of osteogenic sarcoma of the jaw
   Skull Base, 20 (3), 207-12
   DOI 10.1055/s-0029-1246221, PubMed 21318040
7. Lagunova Z, Porojnicu AC, Grant WB, Bruland Ø, Moan JE (2010)
   Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association?
   Mol Nutr Food Res, 54 (8), 1127-33
   DOI 10.1002/mnfr.200900512, PubMed 20512788
8. Moan J, Lagunova Z, Bruland O, Juzeniene A (2010)
   Seasonal variations of cancer incidence and prognosis
   Dermatoendocrinol, 2 (2), 55-7
   DOI 10.4161/derm.2.2.12664, PubMed 21547098
9. Revheim ME, Hole KH, Bruland OS, Haugland HK, Hall KS, Seierstad T (2010)
   DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour
   Acta Oncol, 50 (1), 148-50
   DOI 10.3109/0284186X.2010.516273, PubMed 21110775

Publications 2009

1. Berg A, Dahl AA, Bruland ØS, Bjøro T, Aanensen MS, Fosså SD (2009)
   Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes
   Prostate Cancer Prostatic Dis, 12 (3), 269-76
   DOI 10.1038/pcan.2009.8, PubMed 19290019
2. Brandal P, Bjerkehagen B, Bruland OS, Skjeldal S, Bogsrud TV, Hall KS (2009)
   Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience
   Acta Oncol, 48 (8), 1165-72
   DOI 10.3109/02841860903032809, PubMed 19863225
3. Brekke HR, Kolberg M, Skotheim RI, Hall KS, Bjerkehagen B, Risberg B, Domanski HA, Mandahl N, Liestøl K, Smeland S, Danielsen HE, Mertens F, Lothe RA (2009)
   Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
   Neuro Oncol, 11 (5), 514-28
   DOI 10.1215/15228517-2008-127, PubMed 19182148
4. Bruland ØS, Bauer H, Alvegaard T, Smeland S (2009)
   Treatment of osteosarcoma. The Scandinavian Sarcoma Group experience
   Cancer Treat Res, 152, 309-18
   DOI 10.1007/978-1-4419-0284-9_16, PubMed 20213398
5. Bruland ØS, Høifødt H, Hall KS, Smeland S, Fodstad Ø (2009)
   Bone marrow micrometastases studied by an immunomagnetic isolation procedure in extremity localized non-metastatic osteosarcoma patients
   Cancer Treat Res, 152, 509-15
   DOI 10.1007/978-1-4419-0284-9_30, PubMed 20213412
6. Hall KS, Eriksson M, Bruland OS, Engellau J, Trovik CS (2009)
   Treatment of soft tissue sarcoma of the extremity and trunk wall The Scandinavian Sarcoma Group perspective
   Acta Orthop., 80 334, 52-59
7. Lessnick SL, Dei Tos AP, Sorensen PH, Dileo P, Baker LH, Ferrari S, Hall KS (2009)
   Small round cell sarcomas
   Semin Oncol, 36 (4), 338-46
   DOI 10.1053/j.seminoncol.2009.06.006, PubMed 19664494
8. Norum OJ, Bruland ØS, Gorunova L, Berg K (2009)
   Photochemical internalization of bleomycin before external-beam radiotherapy improves locoregional control in a human sarcoma model
   Int J Radiat Oncol Biol Phys, 75 (3), 878-85
   DOI 10.1016/j.ijrobp.2009.04.039, PubMed 19665318
9. Revheim ME, Seierstad T, Berner JM, Bruland OS, Røe K, Ohnstad HO, Bjerkehagen B, Bach-Gansmo T (2009)
   Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice
   Anticancer Res, 29 (11), 4331-6
   PubMed 20032375
10. Sande TA, Ruenes R, Lund JA, Bruland OS, Hornslien K, Bremnes R, Kaasa S (2009)
    Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial
    Radiother Oncol, 91 (2), 261-6
    DOI 10.1016/j.radonc.2009.02.014, PubMed 19307034
11. Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S (2009)
    The role of radiotherapy in oseosarcoma
    Cancer Treat Res, 152, 147-64
    DOI 10.1007/978-1-4419-0284-9_7, PubMed 20213389
12. Smeland S, Bruland OS, Hjorth L, Brosjo O, Bjerkehagen B, Osterlundh G, Jakobson A, Hall KS, Monge OR, Bjork O, Alvegaard TA (2009)
    Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol
    Acta Orthop., 80 334, 60-66
13. Smeland S, Wiebe T, Monge OR, Brosjo O, Bohling T, Hjorth L, Hall KS, Jakobson A, Alvegaard TA (2009)
    Treatment of localized Ewing sarcoma family of tumors The Scandinavian Sarcoma Group experience
    Acta Orthop., 80, 75-78
14. Søvik S, Skogmo HK, Andersen EK, Bruland ØS, Olsen DR, Malinen E (2009)
    DCEMRI of spontaneous canine tumors during fractionated radiotherapy: a pharmacokinetic analysis
    Radiother Oncol, 93 (3), 618-24
    DOI 10.1016/j.radonc.2009.08.012, PubMed 19747746

Publications 2008

1. Berg A, Bruland ØS, Fosså SD, Nesland JM, Berner A, Schirmer C, Lilleby W (2008)
   Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer
   Prostate, 68 (15), 1607-14
   DOI 10.1002/pros.20826, PubMed 18655095
2. Bjerkehagen B, Smeland S, Walberg L, Skjeldal S, Hall KS, Nesland JM, Småstuen MC, Fosså SD, Saeter G (2008)
   Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital
   Acta Oncol, 47 (8), 1475-82
   DOI 10.1080/02841860802047387, PubMed 18607853
3. Bruland OS, Jonasdottir TJ, Fisher DR, Larsen RH (2008)
   Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy
   Curr. Radiopharm., 1 (3), 203-208
   DOI 10.2174/1874471010801030203
4. Cvancarova M, Samuelsen SO, Magelssen H, Fosså SD (2008)
   Reproduction rates after cancer treatment: experience from the Norwegian radium hospital
   J Clin Oncol, 27 (3), 334-43
   DOI 10.1200/JCO.2007.15.3130, PubMed 19075285
5. Dahle J, Bruland OS, Larsen RH (2008)
   Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation
   Int J Radiat Oncol Biol Phys, 72 (1), 186-92
   DOI 10.1016/j.ijrobp.2008.05.029, PubMed 18722269
6. Erikson A, Tufto I, Bjønnum AB, Bruland ØS, Davies Cde L (2008)
   The impact of enzymatic degradation on the uptake of differently sized therapeutic molecules
   Anticancer Res, 28 (6A), 3557-66
   PubMed 19189635
7. Jebsen NL, Trovik CS, Bauer HC, Rydholm A, Monge OR, Hall KS, Alvegård T, Bruland OS (2008)
   Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study
   Int J Radiat Oncol Biol Phys, 71 (4), 1196-203
   DOI 10.1016/j.ijrobp.2007.11.023, PubMed 18207661
8. Kiserud CE, Magelssen H, Fedorcsak P, Fosså SD (2008)
   [Gonadal function after cancer treatment in adult men]
   Tidsskr Nor Laegeforen, 128 (4), 461-5
   PubMed 18274582
9. Porojnicu AC, Bruland OS, Aksnes L, Grant WB, Moan J (2008)
   Sun beds and cod liver oil as vitamin D sources
   J Photochem Photobiol B, 91 (2-3), 125-31
   DOI 10.1016/j.jphotobiol.2008.02.007, PubMed 18417354
10. Søvik A, Kippenes Skogmo H, Bruland ØS, Rune Olsen D, Malinen E (2008)
    DCEMRI monitoring of canine tumors during fractionated radiotherapy
    Acta Oncol, 47 (7), 1249-56
    DOI 10.1080/02841860802244166, PubMed 18618342
11. Vågane R, Bruland ØS, Fosså SD, Olsen DR (2008)
    Radiological and functional assessment of radiation-induced pulmonary damage following breast irradiation
    Acta Oncol, 47 (2), 248-54
    DOI 10.1080/02841860701630267, PubMed 18210300

Publications 2007

1. Aksnes LH, Bruland ØS (2007)
   Some musculo-skeletal sequelae in cancer survivors
   Acta Oncol, 46 (4), 490-6
   DOI 10.1080/02841860701218642, PubMed 17497316
2. Aksnes LH, Hall KS, Jebsen N, Fosså SD, Dahl AA (2007)
   Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress
   Support Care Cancer, 15 (9), 1087-96
   DOI 10.1007/s00520-007-0227-x, PubMed 17347843
3. Berg A, Berner A, Lilleby W, Bruland ØS, Fosså SD, Nesland JM, Kvalheim G (2007)
   Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
   Int J Cancer, 120 (8), 1603-9
   DOI 10.1002/ijc.22488, PubMed 17230512
4. Berg A, Lilleby W, Bruland OS, Fosså SD (2007)
   10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy
   Int J Radiat Oncol Biol Phys, 69 (4), 1074-83
   DOI 10.1016/j.ijrobp.2007.04.031, PubMed 17703896
5. Dahle J, Borrebaek J, Jonasdottir TJ, Hjelmerud AK, Melhus KB, Bruland ØS, Press OW, Larsen RH (2007)
   Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugate
   Blood, 110 (6), 2049-56
   DOI 10.1182/blood-2007-01-066803, PubMed 17536011
6. Larsen RH, Borrebaek J, Dahle J, Melhus KB, Krogh C, Valan MH, Bruland OS (2007)
   Preparation of TH227-labeled radioimmunoconjugates, assessment of serum stability and antigen binding ability
   Cancer Biother Radiopharm, 22 (3), 431-7
   DOI 10.1089/cbr.2006.321, PubMed 17651051
7. Nilsson S, Franzén L, Parker C, Tyrrell C, Blom R, Tennvall J, Lennernäs B, Petersson U, Johannessen DC, Sokal M, Pigott K, Yachnin J, Garkavij M, Strang P, Harmenberg J, Bolstad B, Bruland OS (2007)
   Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
   Lancet Oncol, 8 (7), 587-94
   DOI 10.1016/S1470-2045(07)70147-X, PubMed 17544845
8. Olsen DR, Bruland OS, Frykholm G, Norderhaug IN (2007)
   Proton therapy - a systematic review of clinical effectiveness
   Radiother Oncol, 83 (2), 123-32
   DOI 10.1016/j.radonc.2007.03.001, PubMed 17499374
9. Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, Bruland OS, Moan J (2007)
   Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
   Lung Cancer, 55 (3), 263-70
   DOI 10.1016/j.lungcan.2006.11.013, PubMed 17207891
10. Søvik A, Malinen E, Skogmo HK, Bentzen SM, Bruland OS, Olsen DR (2007)
    Radiotherapy adapted to spatial and temporal variability in tumor hypoxia
    Int J Radiat Oncol Biol Phys, 68 (5), 1496-504
    DOI 10.1016/j.ijrobp.2007.04.027, PubMed 17674980

Publications 2006

1. Aksnes LH, Hall KS, Folleraas G, Stenwig AE, Bjerkehagen B, Taksdal I, Winderen M, Bruland OS, Saeter G (2006)
   Management of high-grade bone sarcomas over two decades: the Norwegian Radium Hospital experience
   Acta Oncol, 45 (1), 38-46
   DOI 10.1080/02841860500466624, PubMed 16464794
2. Bruland ØS (2006)
   [Jumping after the Swedes]
   Tidsskr Nor Laegeforen, 126 (5), 637
   PubMed 16505887
3. Bruland ØS, Nilsson S, Fisher DR, Larsen RH (2006)
   High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
   Clin Cancer Res, 12 (20 Pt 2), 6250s-6257s
   DOI 10.1158/1078-0432.CCR-06-0841, PubMed 17062709
4. Dahle J, Borrebaek J, Melhus KB, Bruland OS, Salberg G, Olsen DR, Larsen RH (2006)
   Initial evaluation of (227)Th-p-benzyl-DOTA-rituximab for low-dose rate alpha-particle radioimmunotherapy
   Nucl Med Biol, 33 (2), 271-9
   DOI 10.1016/j.nucmedbio.2005.12.004, PubMed 16546683
5. Jonasdottir TJ, Fisher DR, Borrebaek J, Bruland OS, Larsen RH (2006)
   First in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agent
   Anticancer Res, 26 (4B), 2841-8
   PubMed 16886603
6. Larsen RH, Saxtorph H, Skydsgaard M, Borrebaek J, Jonasdottir TJ, Bruland OS, Klastrup S, Harling R, Ramdahl T (2006)
   Radiotoxicity of the alpha-emitting bone-seeker 223Ra injected intravenously into mice: histology, clinical chemistry and hematology
   In Vivo, 20 (3), 325-31
   PubMed 16724665
7. Lipton A, Berenson JR, Body JJ, Boyce BF, Bruland OS, Carducci MA, Cleeland CS, Clohisy DR, Coleman RE, Cook RJ, Guise TA, Pearse RN, Powles TJ, Rogers MJ, Roodman GD, Smith MR, Suva LJ, Vessella RL, Weilbaecher KN, King L (2006)
   Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference
   Clin Cancer Res, 12 (20 Pt 2), 6209s-6212s
   DOI 10.1158/1078-0432.CCR-06-1213, PubMed 17062702
8. Malinen E, Søvik A, Hristov D, Bruland ØS, Olsen DR (2006)
   Adapting radiotherapy to hypoxic tumours
   Phys Med Biol, 51 (19), 4903-21
   DOI 10.1088/0031-9155/51/19/012, PubMed 16985278
9. Søvik A, Malinen E, Bruland ØS, Bentzen SM, Olsen DR (2006)
   Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study
   Phys Med Biol, 52 (2), 499-513
   DOI 10.1088/0031-9155/52/2/013, PubMed 17202629

Publications 2005

1. Brustugun OT, Reed W, Poulsen JP, Bruland OS (2005)
   Primary osteosarcoma of the breast
   Acta Oncol, 44 (7), 767-70
   DOI 10.1080/02841860500254897, PubMed 16227171
2. Dale E, Hellebust TP, Bruland ØS, Olsen DR (2005)
   Comparative analyses of the dynamic properties of the bladder wall studied by repetitive pelvic CT scans of patients and cryo-sections of cadavers
   Br J Radiol, 78 (930), 528-32
   DOI 10.1259/bjr/82990907, PubMed 15900058
3. Eikenes L, Tari M, Tufto I, Bruland OS, de Lange Davies C (2005)
   Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts
   Br J Cancer, 93 (1), 81-8
   DOI 10.1038/sj.bjc.6602626, PubMed 15942637
4. Fosså SD, Magelssen H, Melve K, Jacobsen AB, Langmark F, Skjaerven R (2005)
   Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report
   J Natl Cancer Inst Monogr (34), 77-82
   DOI 10.1093/jncimonographs/lgi019, PubMed 15784830
5. Henriksen G, Bruland OS, Larsen RH (2005)
   Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies
   Anticancer Res, 25 (1A), 9-15
   PubMed 15816513
6. Magelssen H, Haugen TB, von Düring V, Melve KK, Sandstad B, Fosså SD (2005)
   Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?
   Eur Urol, 48 (5), 779-85
   DOI 10.1016/j.eururo.2005.05.002, PubMed 15963629
7. Nilsson S, Larsen RH, Fosså SD, Balteskard L, Borch KW, Westlin JE, Salberg G, Bruland OS (2005)
   First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases
   Clin Cancer Res, 11 (12), 4451-9
   DOI 10.1158/1078-0432.CCR-04-2244, PubMed 15958630
8. Norum J, Bruland ØS, Spanne O, Bergmo T, Green T, Olsen DR, Olsen JH, Sjåeng EE, Burkow T (2005)
   Telemedicine in radiotherapy: a study exploring remote treatment planning, supervision and economics
   J Telemed Telecare, 11 (5), 245-50
   DOI 10.1258/1357633054471858, PubMed 16035967
9. Onda M, Bruland ØS, Pastan I (2005)
   TP-3 immunotoxins improve antitumor activity in mice with osteosarcoma
   Clin Orthop Relat Res (430), 142-8
   DOI 10.1097/01.blo.0000137544.30200.b6, PubMed 15662316